tgAAC94: Additional Phase I/II data

In an ongoing Phase I/II trial in 61 evaluable patients, intra-articular tgAAC94 was safe and

Read the full 152 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE